bioAffinity Technologies (BIAFW) Financial Statements

Price: $2
Market Cap: $26.98M
Avg Volume: -
Country: US
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Beta: 2.934
52W Range: $1.29-2.44
Website: bioAffinity Technologies

Overview of Financial Statements

Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:

  • Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
  • Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
  • Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.

This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of bioAffinity Technologies.


Income Statement

Breakdown December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Revenue $2.53M $4.80K $- $- $-
Cost of Revenue $1.99M $-0.00B $4.82K $22.24K $40.28K
Gross Profit $542.02K $4.34K $-4.82K $-22.24K $-40.28K
Gross Profit Ratio 21.40% 90.28% 0.00% 0.00% 0.00%
Research and Development Expenses $1.72M $1.29M $1.33M $1.61M $1.85M
General and Administrative Expenses $6.79M $2.73M $880.77K $994.34K $-
Selling and Marketing Expenses $- $- $- $- $-
Selling General and Administrative Expenses $6.79M $2.73M $880.77K $994.34K $1.20M
Other Expenses $-27.80K $-1.87M $724.93K $-4.28M $-
Operating Expenses $8.52M $4.02M $2.21M $2.60M $3.05M
Cost and Expenses $10.51M $4.02M $2.21M $2.60M $3.09M
Interest Income $122.13K $46.71K $-0.00B $1.07K $2.78K
Interest Expense $37.12K $2.53M $1.00M $382.17K $214.83K
Depreciation and Amortization $249.59K $10.18K $4.82K $22.24K $40.28K
EBITDA $-7.72M $-5.82M $-1.48M $-6.86M $-3.05M
EBITDA Ratio -304.98% -121196.96% 0.00% 0.00% 0.00%
Operating Income $-7.97M $-4.01M $-2.21M $-2.60M $-3.09M
Operating Income Ratio -314.84% -83511.51% 0.00% 0.00% 0.00%
Total Other Income Expenses Net $57.21K $-4.14M $-4.12M $-4.66M $-212.06K
Income Before Tax $-7.92M $-8.15M $-6.32M $-7.27M $-3.30M
Income Before Tax Ratio -312.58% -169720.05% 0.00% 0.00% 0.00%
Income Tax Expense $20.99K $2.46K $1.95K $2.75K $3.20K
Net Income $-7.94M $-8.15M $-6.33M $-7.27M $-3.31M
Net Income Ratio -313.41% -169771.25% 0.00% 0.00% 0.00%
EPS $-0.91 $-1.81 $-0.86 $-0.99 $-0.45
EPS Diluted $-0.91 $-1.81 $-0.86 $-0.99 $-0.45
Weighted Average Shares Outstanding 8.75M 4.50M 7.38M 7.38M 7.38M
Weighted Average Shares Outstanding Diluted 8.75M 4.50M 7.38M 7.38M 7.38M
SEC Filing Source Source Source Source Source

Balance Sheet

Breakdown December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Cash and Cash Equivalents $2.82M $11.41M $1.36M $83.11K $578.48K
Short Term Investments $- $- $- $- $-
Cash and Short Term Investments $2.82M $11.41M $1.36M $83.11K $578.48K
Net Receivables $811.67K $10.49K $1.53K $1.53K $1.53K
Inventory $18.48K $5.54K $71.85K $28.35K $-
Other Current Assets $321.02K $119.77K $4.22K $5.67K $37.49K
Total Current Assets $3.97M $11.96M $1.44M $118.66K $617.51K
Property Plant Equipment Net $1.99M $214.44K $4.63K $9.45K $28.80K
Goodwill $1.40M $- $- $- $-
Intangible Assets $833.47K $- $- $- $-
Goodwill and Intangible Assets $2.24M $- $- $- $-
Long Term Investments $- $- $- $- $-
Tax Assets $- $- $- $- $-
Other Non-Current Assets $16.06K $6.00K $10.44K $17.50K $12.50K
Total Non-Current Assets $4.25M $220.44K $15.07K $26.95K $41.30K
Other Assets $- $- $- $- $-
Total Assets $8.22M $12.18M $1.45M $145.60K $658.81K
Account Payables $604.79K $345.04K $230.41K $191.39K $103.42K
Short Term Debt $460.17K $251.75K $11.20M $9.95M $4.01M
Tax Payables $- $- $- $- $-
Deferred Revenue $33.06K $- $- $- $-
Other Current Liabilities $1.15M $541.89K $1.60M $976.10K $579.93K
Total Current Liabilities $2.25M $1.14M $13.04M $11.12M $4.69M
Long Term Debt $1.12M $- $160.18K $53.47K $-
Deferred Revenue Non-Current $- $- $- $- $-
Deferred Tax Liabilities Non-Current $- $- $- $- $-
Other Non-Current Liabilities $- $596.79K $4.04M $4.04M $-
Total Non-Current Liabilities $1.12M $596.79K $4.20M $4.10M $-
Other Liabilities $- $-596.79K $--0.00B $- $-
Total Liabilities $3.37M $1.14M $17.24M $15.22M $4.69M
Preferred Stock $- $12.18B $4.04M $4.04M $4.04M
Common Stock $65.76K $58.67K $18.74K $18.72K $18.72K
Retained Earnings $-44.60M $-36.67M $-28.51M $-22.19M $-14.92M
Accumulated Other Comprehensive Income Loss $- $- $-4.04M $-4.04M $-18.72K
Other Total Stockholders Equity $49.39M $-12.13B $12.70M $7.10M $6.84M
Total Stockholders Equity $4.86M $11.04M $-15.79M $-15.07M $-4.04M
Total Equity $4.86M $11.04M $-15.79M $-15.07M $-4.04M
Total Liabilities and Stockholders Equity $8.22M $12.18M $1.45M $145.60K $658.81K
Minority Interest $- $- $- $- $-
Total Liabilities and Total Equity $8.22M $12.18M $1.45M $145.60K $658.81K
Total Investments $- $- $- $- $-
Total Debt $1.58M $251.75K $11.36M $10.01M $4.01M
Net Debt $-1.24M $-11.16M $10.00M $9.92M $3.43M

Cash Flow Statement

Breakdown December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Net Income $-7.94M $-8.15M $-6.33M $-7.27M $-3.31M
Depreciation and Amortization $249.59K $10.18K $4.82K $22.24K $40.28K
Deferred Income Tax $-964.09K $- $3.84M $- $-
Stock Based Compensation $748.82K $248.59K $43.01K $275.73K $-
Change in Working Capital $900.79K $114.20K $632.82K $482.62K $322.01K
Accounts Receivables $311.37K $-8.96K $- $- $-0.00B
Inventory $-12.94K $-5.54K $- $- $-
Accounts Payables $-14.50K $114.64K $39.02K $87.97K $-39.82K
Other Working Capital $616.87K $14.07K $593.80K $394.65K $361.54K
Other Non Cash Items $964.09K $3.71M $-244.35K $4.28M $575.11K
Net Cash Provided by Operating Activities $-6.04M $-4.07M $-2.05M $-2.21M $-2.49M
Investments in Property Plant and Equipment $-22.90K $-219.99K $- $-2.89K $-11.40K
Acquisitions Net $-2.19M $- $- $- $-
Purchases of Investments $- $- $- $- $-
Sales Maturities of Investments $- $- $- $- $-
Other Investing Activities $-2.21M $- $- $- $-
Net Cash Used for Investing Activities $-2.21M $-219.99K $- $-2.89K $-11.40K
Debt Repayment $-344.98K $-694.98K $-3.51M $-1.72M $-2.33M
Common Stock Issued $- $6.03M $- $- $-
Common Stock Repurchased $- $--0.00B $- $- $-
Dividends Paid $- $- $- $- $-
Other Financing Activities $-344.98K $9.01M $6.83M $3.43M $-
Net Cash Used Provided by Financing Activities $-344.98K $14.34M $3.33M $1.72M $2.33M
Effect of Forex Changes on Cash $-0.00B $- $- $- $-
Net Change in Cash $-8.59M $10.05M $1.28M $-495.38K $-166.59K
Cash at End of Period $2.82M $11.41M $1.36M $83.11K $578.48K
Cash at Beginning of Period $11.41M $1.36M $83.11K $578.48K $745.08K
Operating Cash Flow $-6.04M $-4.07M $-2.05M $-2.21M $-2.49M
Capital Expenditure $-22.90K $-219.99K $- $-2.89K $-11.40K
Free Cash Flow $-6.06M $-4.29M $-2.05M $-2.21M $-2.50M